| Followers | 108 |
| Posts | 7703 |
| Boards Moderated | 0 |
| Alias Born | 11/23/2007 |
Monday, March 11, 2024 4:31:59 PM
This is perhaps the best explanation of the share price action here I have ever heard
Recent QNRX News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 08:38:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 01:35:33 PM
- Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results • GlobeNewswire Inc. • 03/26/2026 12:30:00 PM
- Quoin advances QRX003 development after positive FDA meeting on Netherton syndrome • IH Market News • 03/25/2026 03:07:12 PM
- Quoin Pharmaceuticals Provides Clinical and Regulatory Update from Constructive Type C Meeting with U.S. FDA for QRX003 in Netherton Syndrome • GlobeNewswire Inc. • 03/25/2026 12:30:00 PM
- Quoin Pharmaceuticals to Announce Corporate Update and Fourth Quarter and Full-Year 2025 Financial Results on Thursday, March 26, 2026 • GlobeNewswire Inc. • 03/19/2026 12:30:00 PM
- Quoin Pharmaceuticals Announces FDA Grants Fast Track Designation for QRX003 for the Treatment of Netherton Syndrome • GlobeNewswire Inc. • 03/11/2026 12:30:00 PM
- NETHERTON NOW Recognizes Rare Disease Day and Highlights Growing Global Awareness of Netherton Syndrome • GlobeNewswire Inc. • 02/26/2026 01:30:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/18/2026 01:14:32 AM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/17/2026 08:20:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2026 10:24:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2026 10:20:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2026 10:18:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2026 10:17:29 PM
- Quoin Pharmaceuticals Announces Submission to Japanese MHLW for Orphan Drug Designation for QRX003 in Netherton Syndrome • GlobeNewswire Inc. • 01/27/2026 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/20/2026 10:18:14 PM
- Quoin Pharmaceuticals Files Breakthrough Medicine Designation Application in Saudi Arabia for QRX003 in Netherton Syndrome • GlobeNewswire Inc. • 01/20/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/05/2025 01:00:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/03/2025 10:39:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/17/2025 10:00:56 PM
